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Incomplete data is common in both observational studies and clinical trial-
s. Ignoring missing data may produce seriously biased estimators and could lead
to misleading results. During the last three decades, a vast amount of work has
been done in this area. The approaches can be classified into the following main
categories: imputation methods, likelihood-based methods and inverse probability
weighting methods. Longitudinal and crossover studies with repeated measures are
particularly subject to missing observations. Various methods, including general-
ized estimating equations (GEE) (Liang and Zeger, 1986), weighted GEE (WGEE)
(Robins, Rotnitzky and Zhao, 1995) and multiple imputations, have been proposed
to cope with missing data in longitudinal studies. However, very few researchers
have explored the missing data issue in crossover studies. In addition to reviewing
and critiquing the methods dealing with missing observations in general and in re-
peated measures, in this dissertation, we propose a new weighting approach for GEE
to estimate the regression parameters in crossover studies. The proposed method
provides consistent and asymptotically normally distributed estimators. Simulation
and asymptotic efficiency results indicate that the proposed estimators are more
efficient than both regular GEE and WGEE. Applications of the proposed method
are illustrated with real data.
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Missing data is a common problem in both observational and controlled s-
tudies. Ignoring missing data may produce seriously biased estimators and could
be lead to misleading results. During the last three decades, a large amount of
research has been done in analyzing incomplete data. As a result, a rich taxonomy
of missing data concepts and methods as well as various data analysis tools have
been developed.
One way to deal with missingness is the complete-case (CC) method where
cases with any missing values are simply discarded. Advantages of this method
are simplicity of implementation and the fact that valid inferences can be obtained
when the data are missing completely at random (MCAR). However, when data
are missing at random (MAR) but not MCAR, the CC method will produce bi-
ased estimates. As a result, several approaches have been proposed to improve CC
analysis. These are likelihood-based methods (Little and Rubin, 2002), imputa-
tion methods (Rubin, 1987; Schafer, 1997), and the inverse probability weighting
(IPW) method and its efficient version (Zhao and Lipsitz, 1992; Robins, Rotnitzky
and Zhao, 1994; Carpenter, Kenward, Vansteelandt, 2006). In the likelihood-based
method, the marginal likelihood of the observed data is maximized. In the impu-
tation method, the incomplete cases are imputed with the conditional mean of the
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missing part given the observed part. It’s also possible to impute random values.
The regular analysis model then can be applied. In the IPW method, the inverse of
the probability that a record is missing given the observed values is used to adjust
the estimating equation; thus a model for the missingness indicator R is needed,
where R = 1 if an outcome is observed and R = 0 otherwise.
Longitudinal studies are characterized by a sample design which specifies re-
peated observations on the same experimental unit. Failure to obtain a full set of
observations on a given subject results in incomplete data and/or unbalanced de-
signs. Such missingness is a common problem in longitudinal studies. The analysis
of non-Gaussian longitudinal data is difficult partly because few models for the joint
distribution of the repeated observations for a subject are available. On the other
hand, longitudinal data offer the advantage that data from distinct subjects are
independent. In longitudinal studies, outcomes that are repeatedly measured over
time may be correlated and some may be missing. Liang and Zeger (1986) proposed
the generalized estimating equation (GEE) approach for longitudinal data, whose
solutions are consistent. Their methods make assumptions about the mean and
variance but not necessarily about the full distribution of a random variable. The
estimates obtained from solving the GEE are consistent under MCAR, but might
be biased under MAR. Robins, Rotnitzky and Zhao (1995) proposed a weighted
generalized estimating equation (WGEE) method, which is in essence an applica-
tion of the IPW method to repeated measures, for obtaining unbiased estimates in
analyzing incomplete longitudinal data under MAR.
A crossover study is distinguished from a parallel group study by each subject
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receiving a sequence of experimental treatments. The main advantage is that the
treatments are compared within subjects. Therefore, every subject provides a direct
comparison of the treatments that he or she has received, eliminating many unknown
confounders. Crossover studies have been extensively used in clinical studies. As in
longitudinal studies, repeated measures are taken on the same subject, and therefore
missing data is also a common problem in crossover studies. However, few research
results have been reported in this area.
We propose a new weighting approach for GEE to estimate the regression pa-
rameters in crossover studies. Simulations and asymptotic efficiency results indicate
that the proposed estimators are more efficient than both regular GEE and WGEE.
Applications of the proposed method to real data are also discussed.
This dissertation is organized as follows. In Chapter 2, we review the complete-
case method and other conventional approaches to missing data analysis. Missing
data methods used in repeated measures, especially for longitudinal data, are de-
scribed in Chapter 3. A new weighted estimator for improvement of estimation
efficiency is introduced in Chapter 4. In Chapter 5, simulation studies are per-
formed to validate the theoretical results. Applications to real data are also shown
in Chapter 5. In Chapter 6, we summarize the results and also give the potential
direction of future work.
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Chapter 2
Methods to Handle Missing Data
2.1 Notation and Terminology
The following terminology is based on the standard framework coined by Rubin
(1976) and Little and Rubin (2002). Assume that for each independent unit in
the study, we have observations Yij, i = 1, ..., n, j = 1, ..., T , written in vector no-
tation as Yi = (Yi1, ..., YiT )
′, where i indicates the subject and j the measurement
occasion. Define Xi as covariates, which throughout this dissertation are always
observed. Generally, Xi can have missing values as well. Let Rij denote missing
data indicators, where Rij = 1 if Yij is observed, and 0 otherwise. Define the vec-
tor Ri = (Ri1, ..., RiT )
′, parallel to Yi. Let πij denote the observation probability.
Define the vector πi = (πi1, ..., πiT )
′. One can partition Yi into two subvectors: Y
o
i ,
the vector of observed values, and Y mi , the vector of missing values. The full data
(Xi, Yi, Ri) i = 1, ..., n, consist of the covariates, the complete data, together with
the missing data indicators.
A nonresponse process is said to be missing completely at random (MCAR) if
the missingness is independent of observed and unobserved data. That is,
P (Rij = 1|Xi, Yi) = P (Rij = 1). (2.1)
The nonresponse process is said to be missing at random (MAR) if the miss-
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ingness is independent of the unobserved data conditional on the observed data.
That is
P (Rij = 1|Y oi , Y mi , Xi) = P (Rij = 1|Y oi , Xi). (2.2)
The third missingness mechanism is called missing not at random (MNAR) where
the probability that a measurement is missing depends on unobserved data.
2.2 Complete-Case Method
A commonly used treatment of missing data in many statistical software sys-
tems is complete-case (CC) analysis, where the records with missing values are
simply deleted. Then the data used in the analysis only includes the complete cas-
es. When the density of Y , denoted by P (Y |X; θ), is known, where θ is the vector





P (Yi|Xi; θ)Ri . (2.3)




RiU(Yi|Xi; θ) = 0, (2.4)
where U(Yi|Xi; θ) = (∂/∂θ)logP (Yi|Xi; θ)
When the missingness mechanism is missing completely at random (MCAR),
















Thus, the estimator obtained from CC analysis, θ̂CC , is consistent (Lehmann and
Casella, 1998), and
√














= π−1i E[Ui(Yi|Xi, θ)UTi (Yi|Xi, θ)]−1.
When the missingness mechanism is not MCAR, E(Ri|Yi, Xi) will depend on Yi.
Thus equation (2.5) will not hold and the estimator θ̂CC will be biased (Little and
Rubin, 2002). On the other hand, even if the complete-case method yields a con-
sistent estimator when R is independent of Y , discarding incomplete cases seems to
be an unnecessary waste of information.
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2.3 Likelihood-based Method
Compared to the complete-case method, an obviously improved approach is




[P (Ri = 1|Y oi , Y mi , Xi)Pθ(Y oi |Y mi , Xi)P (Y mi |Xi)]Ri
×
[∫
P (Ri = 1|Y oi , ymi , Xi)Pθ(Y oi |ymi , Xi)P (ymi |Xi)dymi
]1−Ri
. (2.6)
Under MAR, P (Ri|Y oi , Y mi , Xi) = P (Ri|Y oi , Xi), and P (Ri|Y oi , Y mi , Xi) and
















i |Y mi , Xi)]Ri [Pθ(Y oi |Xi)]1−Ri . (2.7)







i |Y mi , Xi; θ) + (1−Ri)U(Y oi ; θ)] = 0, (2.8)
where
U(Y oi |Y mi , Xi; θ) = (∂/∂θ)logPθ(Y oi |Y mi , Xi),
and
U(Y oi |Xi; θ) = (∂/∂θ)logPθ(Y oi |Xi).
This is an unbiased estimating equation. Therefore, the estimator θ̂ML is consistent
and
√
n(θ̂ML− θ0) is asymptotically normally distributed with mean 0 and variance
ΣML ={
E[π(Y oi , Xi)(−
∂
∂θ








If the fully parametric models can be correctly specified, the estimators are
usually more efficient. Generally it’s straightforward to fit a multivariate normal
model using standard statistical packages. However, likelihood-based estimation
relies heavily on parametric model assumptions and the ignorability assumption,
which generally cannot be jointly checked from the observed data. Thus estimates
are sensitive to model misspecification. In addition, even with complete data, if the
focus is on models for the marginal distribution of the response, then fully parametric
models for certain non-Gaussian data that preserve the marginal expectation of
Yit given Xi can often be cumbersome and computationally difficult when Xi is
multivariate with continuous components (Prentice, 1988).
2.4 Multiple Imputation (MI) Method
Multiple imputation is a Monte Carlo approach to the analysis of incomplete data.
Multiple imputation shares the same underlying philosophy as the EM algorithm
and data augmentation: solving an incomplete-data problem by repeatedly estimat-
ing and solving the complete-data version (Molenberghs and Kenward, 2007). In
multiple imputation, the unknown missing values of Ym are replaced by simulated




(D). Each of the D completed data sets is analyzed by standard
complete-data methods. The variability among the results of the D analyses pro-
vides a measure of the uncertainty due to missing data, which, when combined with
measures of ordinary sample variation, lead to a single inferential statement about
the parameters of interest.
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Theoretical Justifications
At the heart of the MI method is a Bayesian argument. The idea, first proposed by
Rubin (1978), is to relate the observed-data posterior distribution to the complete-
data posterior distribution that would have been obtained if we had observed the
missing data. Then the posterior distribution for θ, the parameter of interest, is
given by:
P (θ|Y o) =
∫





P (θ, Y m|Y o)dY m
=
∫
P (θ|Y o, Y m)P (Y m|Y o)dY m
= EYm|Y o [P (θ|Y o, Y m)]. (2.9)
When the posterior mean and variance are adequate summaries of the posterior
distribution, the content of equation (2.9) can be effectively represented by the










θP (θ|Y o, Y m)dθdY m





θ̂d = θ̂MI , (2.10)
where D is the number of imputations and θ̂d is the maximum likelihood estimate of
θ calculated by using the dth completed data set, and θ̂MI is the multiple imputation
estimator of θ. The value of D varies, but typically researchers set D = 5 (Schafer,
1999).
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P (θ|Y o, Y m)P (Y m|Y o)dY mdθ
− [P (θ|Y o, Y m)P (Y m|Y o)dY mdθ]2
=
∫
P (Y m|Y o)
[∫
θ2P (θ|Y m, Y o)dθ −
(∫





P (Y m|Y o)
[∫





P (θ|Y m|Y o)
(∫














(θ̂MI − θ̂d)2 = V̄ +B, (2.11)
where Vd is the complete-data posterior variance calculated from the dth data
set, V̄ = 1/D
∑D
d=1 Vd is the average of Vd over the imputed data sets and B =
[1/(D − 1)]
∑D
d=1(θ̂MI − θ̂d)2 is the between-imputation variance.
Making Proper Imputations
Multiple imputation is attractive because it can be highly efficient even for small
values of D. The efficiency of an estimate based on D imputations is approximately
(1 + γ/D)−1, where γ is the fraction of missing information for the quantity being
estimated. Therefore, there is thought to be little advantage in producing and
analyzing more than a few imputed data sets (Little and Rubin, 2002).
For general missing data patterns with a multivariate normal imputation mod-
el, small-sample draws can be constructed using Markov Chain Monte Carlo (MCM-
C) methods (Schafer, 1997, Section 5.4). Schafer (1997), along with many software
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packages including SAS/STAT, uses data augmentation, one type of MCMC, to get
random draws from the posterior distribution of the parameter of interest θ. Closely
related to Gibbs sampling, data augmentation is an iterative method of simulating
the posterior distribution of θ. Start with an initial draw from an approximation
to the posterior distribution of θ. The EM estimate of θ is usually a good starting
value. Given a value of drawn at iteration t:
I-Step: Draw Y m(t+1) from density p(y
m
(t+1)|Y o, θ(t));
P-Step: Draw θ(t+1) from density p(θ|Y o, Y m(t+1)).
The iterative procedure can be shown eventually to yield a draw from the joint
posterior distribution of (Y m, θ) given Y o in the sense that as t tends to infinity,
this sequence converges to a draw from the joint distribution of (Y m, θ) given Y o .
Specifically, in our example the model for p(Y m|Y o) is known as the imputation
model. For the resulting estimates of θ to have the correct frequentist properties,
in terms of consistency and correct coverage of confidence intervals, careful choice
of p(Y m|Y o) is crucial. Additionally, the variables that are included in Y o must
include all the variables that make the response missing at random.
Single imputation methods are simple to use, but in general they might not
conform to statistical principles for making inferences, particularly when sources of
uncertainty are concerned in determining treatment effect.
Multiple imputation (MI) methods allow using large amounts of information
about auxiliary variables that are not included in the analysis model but can be
used in the imputation model. This generally would lead to more accurate im-
putations. In addition, MI methods are easy to use and are available in many
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standard statistical software packages, such as PROC MI and MIANALYZE in
SAS. However, MI does rely on parametric assumptions, which generally cannot be
verified from the observed data. Furthermore, the data model P (Y |X, θ) may be
incompatible with the imputation model P (Y |V,X;ϕ), where V are the auxiliary
variables. Compatible models have the property that the data model is what is
left when auxiliary variables are integrated out of the imputation model, that is,∫
P (Y |V,X;ϕ)P (V |X;ϕ)dV = P (Y |X;ϕ).
As the number of imputations (D) increases, the results from the likelihood
method and multiple imputation method should converge (Molenberghs and Ken-
ward,2007). When the number of imputations is finite, the MLE are actually more
efficient although the differences may be very small.
When covariates are missing, MI offers an intuitively attractive and very man-
ageable method for dealing with potentially very complex problems for which like-
lihood analyses maybe impracticable or, at least, very awkward.
As Meng (1994) shows, it is one of the great strengths of MI that the impu-
tation and substantive models do not have to be the same (usually the imputation
model is more general than the analysis model). Meng introduces the term ‘uncon-
genial’ for an imputation model which is not consistent with the substantive model.
It’s with these that MI has much to offer in the current setting.
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2.5 Inverse Probability Weighting Method
As we know, random selection of the available data may yield biased estima-
tors. A similar problem occurs when the observations come from a complex survey
design wherein the subjects are sampled from a finite population with unequal se-
lection probabilities. Analyzing such design-based data as a simple random sample
can also introduce bias. To reduce selection bias, the inverse probability weighting
(IPW) idea was introduced by Horvitz and Thompson (1952). The key idea of IPW
is straightforward and intuitively attractive; that is, by weighting each subject in
the data with inverse selection probability, one can produce unbiased estimators.
Based on the IPW idea, Zhao and Lipsitz (1992) proposed a weighted estimating
equation for general regression.
2.5.1 Inverse Probability Weighting (IPW)






U(Yi|Xi; θ) = 0, (2.12)
where πi(Yi, Xi) is the observation probability and U(Yi|Xi; θ) is the quasi-score
function of P (Yi|Xi; θ) .
Zhao and Lipsitz (1992) showed that the estimator θ̂W is consistent and asymp-
totically normal with variance ΣW = I−1v ΣθI−1v , where Iv = E[−(∂/∂θ)U(Yi|Xi; θ)],
and Σθ = E
[
1/π(Y,X)U(Y |X; θ)U(Y |X; θ)T
]
.
When πi is unknown, which is the case in many situations, it can be estimated
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in conjunction with estimating θ. A parametric model (Zhao, Lipsitz and Lew 1996)
can be built for πi, for example, πi(α) = f(R|Y oi , Xi;α), where f is a known function
indexed by unknown parameter α. Then θ and α can be estimated simultaneously
by solving the following estimating equations:
UW (θ, α) =
∑ Ri
πi(Y oi , Xi;α)





U(Ri|Y oi , Xi;α)
=









 θ̂Wα − θ0
α̂− α0
 d→ N (0,Σθ,α) , (2.14)
where Σθ,α has the form of I−1ΣI−1,
I =
 (∂/∂θ)UWi (Y |X; θ, α) (∂/∂α)UWi (Y |X; θ, α)







































d→ N [0, I−1v (Σθ − Ω12I−1α Ω12)I−1v ]. (2.15)
Hence, θ̂Wα is more efficient than θ̂W , which assumes the observation distribution is
known.
Alternatively, a nonparametric model of πi can be constructed. Wang et al
(1997) considered nonparametric kernel smoothers for the selection probability πi.
The nonparametric estimate avoids the nonrobustness of parametric methods men-
tioned above. However, the nonparametric method encounters another problem of
bandwidth selection. The selection of a good value of bandwidth is crucial to ensure
the asymptotic unbiasedness of the estimation.
2.5.2 Improved IPW (Augmented IPW)
The IPW method does not use all observed information. Therefore θ̂W is not
efficient but can be improved by incorporating all available information in incomplete
cases. Robins, Rotnizky and Zhao (1994) showed that the efficiency of IPW can be
improved by subtracting the projection of the estimating function onto the nuisance
tangent space, which is the closed span of nuisance scores. Lipsitz, Ibrahim and
Zhao (1999) further explored the properties of this approach.













E [Uθ,i(Y |X)|Y oi , Xi]
]
. (2.16)
































n(θ̂AW − θ0) is asymptotic normally distributed with mean 0 and vari-
ance I−1v ΣAWI−1v . It is clear that the improved inverse probability weighting method
reduces the variance of the IPW method.
Often, P (Y m|Y o, X) and P (R = 1|Y o, X) are unknown. As shown in previous
sections dealing with the imputation methods, P (Y m|Y o, X), the imputation model,
needs to be correctly specified. In the inverse probability weighting method, P (R =
1|Y o, X), the model for the probability of observing the data, needs to be correct.
However, in the augmented IPWmethod, a consistent estimator of θ can be obtained
if either, not necessarily both, of P (R = 1|Y o, X) or P (Y m|Y o, X) is correctly
specified. This property is called double robustness. Therefore, these estimators
enjoy greater robustness against model misspecification than both imputation and
IPW estimators.
Specifically, efficient IPW estimators require three models: (1) The substantive
model which relates the outcome to explanatory variables/covariates of interest. (2)
A model for the probability of observing the data. This is usually a logistic model of
some form. (3) A model for the joint distribution of the partially and fully observed
data, which is compatible with the substantive model in (1).
The interesting property of (2.16) is that if either model (2) or (3) is misspec-
ified, but not both, the estimators in model (1) remain consistent. By contrast, if
model (2) is wrong, the inverse probability weighting estimator will be inconsistent,
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whereas multiple imputation will generate inconsistent estimators if model (3) is
not correctly specified. Lipsitz et al. (1999) proposed parametric approaches to
specify those distributions under the assumption of MAR. The steps to improve the
efficiency are also discussed in Rotnitzky and Robins (1997).
Inverse probability weighting is generally simple to implement and available
in standard statistical packages with weighted analyses. It’s in essence a semipara-
metric method, making assumptions only about the mean and variance. Thus it
tends to be more robust than the likelihood-based method, which requires assuming
a parametric model for the full-data response distribution. An important advantage
of the IPW method is that under a correctly specified model for observation, many
auxiliary variables can be accommodated, including information on previously ob-
served outcomes. This would generally improve the prediction of future outcomes
being observed or missed. It’s able to handle reasonably well the missing data in dis-
crete variables. In addition, IPW method can be extended to estimating quantities
other than the mean, such as the median.
Generally the IPW estimator is not efficient. But its efficiency can be signifi-
cantly improved by AIPW, which also possesses the doubly-robust property. Anoth-
er potential disadvantage of the IPW method is that it needs to make assumptions
about the observation probability. Usually a logistic regression model is assumed.
However, the possibility of correctly specifying a probability model for observations
is much greater than specifying a correct response model.
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Chapter 3
Missing Data Analysis in Longitudinal Study
3.1 Notation and Assumptions
Consider a repeated measure study where subjects are assessed over a fixed
interval from time 1 to T . Let Yi = (Yi1, Yi2, . . . , YiT )
T be the vector of outcome





i2, . . . , X
T
iT )
T , where Xit is a vector of explanatory variables associated
with Yit and includes the constant 1 as a component. Here Xit may be a vector of
baseline explanatory variables X∗i , such as, treatment indicator, gender, age, and
possibly pretreatment clinical status, or a deterministic function of time and the
baseline variables, e.g., Xit = X
∗
i t. It’s assumed that Xi is completely observed for
every subject. The marginal distribution of Yit given Xi is
E(Yit|Xi) = g−1(ηit) = g−1(XTi θ), (3.1)
where θ is a vector of unknown parameters and g is a known link function.
Due to various reasons, the full vector Yi is not always observed. Define
Ri = (Ri1, Ri2, ..., RiT )
T to be the observation indicator for Yi. Let Rit = 1 if
subject i is observed at time t and Rit = 0 otherwise. The missing data pattern is
assumed to be monotone, that is, Yik is not observed if Yij is missing, where k > j,
which is often the case in repeated measure studies, such as longitudinal studies and
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crossover studies. Let W̄it = {Xi, Yi1, . . . , Yi(t−1)} be the entire history of subject i
before time t.
A nonresponse process is said to be missing completely at random (MCAR) if
the missingness is independent of both observed and unobserved data. That is,
P (Rit = 1|Ri(t−1) = 1, W̄it, Yit) = P (Rit = 1|Ri(t−1) = 1). (3.2)
The nonresponse process is said to be missing at random (MAR) if the miss-
ingness is independent of the unobserved data conditional on the observed data,
that is
P (Rit = 1|Ri(t−1) = 1, W̄it, Yit) = P (Rit = 1|Ri(t−1) = 1, W̄it). (3.3)
Another missingness mechanism is missing not at random (MNAR) where the prob-
ability of a measurement being missing depends on unobserved data.
Throughout, we shall assume MAR without stating otherwise and that the
observation probability is bounded away from zero:
P (Rit = 1|Ri(t−1) = 1, W̄it) > σ > 0 (3.4)
3.2 Last Observation Carried Forward (LOCF)
LOCF has been a commonly used single imputation method in longitudinal
study for the last few decades. It’s based on the strong assumption that the outcome
of a participant does not change after dropout, which is generally not the case in
reality. Although using LOCF relies on the plausibility of the assumptions under-
pinning these estimators, the pragmatic justification often stems from the sometimes
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mistaken view that it provides a simple and conservative imputation that will help
prevent approval of ineffective treatments (National Research Council, 2010). How-
ever this is not necessarily the case, since, for example, LOCF is anticonservative in
situations where participants off study treatment generally do worse over time. In
such cases, if many participants discontinue study treatment due to problems with
tolerability, the treatment can be made to look much better than the control by
such an imputation strategy.
3.3 Generalized Estimating Equations (GEE)
The analysis of non-Gaussian longitudinal data is difficult partly because few
models for the joint distribution of the repeated observations for a subject are avail-
able. On the other hand, longitudinal data offers the advantage that data from
distinct subjects are independent. In longitudinal studies, outcomes that are re-
peatedly measured over time may be correlated and some may be missing. Liang
and Zeger (1986) proposed the generalized estimating equation (GEE) approach to
longitudinal data, whose solutions are consistent for θ provided only that the model
for the marginal means of the outcomes at each occasion is correctly specified. This
approach is an extension of quasi-likelihood methods (McCullagh and Nelder, 1989)
to the multivariate regression setting and results in reweighted least squares esti-
mators of the parameter θ. Assuming that the marginal mean µi has been correctly
specified as g(µi) = ηi = X
T
i θ, where g is a known link function, the estimating
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−1Ci(Yi − µi) = 0, (3.5)
where Vi(θ, α) = ϕAi(µi)
1/2Ωi(ρ)Aiµi
1/2, Ai = diag{var(yi1), var(yi2), ..., var(yiT )},
α = (ϕ, ρ), Ωi(ρ) is a “working” correlation matrix of Yi, and
Ci = diag{Ri1, Ri2, ..., RiT}.
One can choose Ωi(ρ) as the identity matrix or the equicorrelation matrix and
the specified correlation structure need not be the correct correlation structure of Yi.
The GEE estimator, θ̂G, is the root of U(θ, α̂) = 0, where α̂ satisfies
√
n(α̂− α∗) =


























Note that the consistency of θ̂G and ΣG depends only on the correct specifi-
cation of the mean, not on the correct choice of the “working” correlation matrix.
However the correct specification of the “working” correlation matrix will help im-
prove the efficiency. In addition, when the “working” correlation matrix represents
the true correlation, the assumption of MCAR can be unnecessary. In summa-
ry, Liang and Zeger (1986) proposed the generalized estimating equation (GEE)
approach to longitudinal data, whose solutions are consistent under MCAR. The
methods avoids the need for multivariate distributions by only assuming a function-
al form of the marginal distribution at each occasion.
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3.4 Weighted Generalized Estimating Equations (WGEE)
Liang and Zeger (1986) pointed out that θ̂G, the solution by solving the GEE,
is consistent under MCAR but not under MAR. Robins, Rotnitzky and Zhao (1995)
proposed a weighted generalized estimating equation (WGEE) for obtaining unbi-
ased GEE estimates under MAR.
Let λ̄it = P (Rit = 1|Ri(t−1), W̄it) be the probability of observing a response at
time t. Typically, λ̄it(α) could be a logistic function. Let α̂ be the partial maximum










Rit{1− λ̄it(α)}1−Rit ]Ri(t−1) . (3.7)














Let Σ = var{Si(α)} be the asymptotic variance of
√
n(α̂ − α). Then Si(α)
simplifies to
∑T
t=1(Rit − λ̄it(α)Ri(t−1))h(W̄it) if λ̄it follows the logistic regression
model logit(λ̄it) = α
Th(W̄it) for some vector function h(·). Define π̄it(α) = λ̄i1(α)×
· · ·× λ̄it(α), where π̄it(α) is the conditional probability of observing subject i at the
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as the T ×T diagonal matrix with diagonal elements △it(α) = Ritπ̄it(α)−1 Then the
WGEE has the following form:





i △i(α̂)(Yi − µi) = 0, (3.10)
where Di = ∂µ
T
i /∂θ, Vi is the “working” covariance matrix. Robins, Rotnitzky
and Zhao (1995) showed that the solution to estimating equation (3.10), θ̂WG, is
consistent and asymptotically normal.
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Chapter 4
Proposed Reweighted Generalized Estimating Equations Method
4.1 Motivation
While the WGEE method offers a very useful alternative to consistently esti-
mating the repeated measures with missing observations, it does have serious disad-
vantages. When the observation probability π̄it in WGEE is small, WGEE estimates
become very unstable. Additionally, the efficiency of a WGEE estimate is sacrificed
for the robustness by assuming only the mean and variance of a distribution. In
order to improve upon the WGEE method, especially the efficiency of WGEE, moti-
vated by the methods of handling missing data in survey research (Brick and Kalton,
1996), we developed a new weighted estimating equation, a reweighted approach, for
repeated measures in the presence of missing observations. The proposed method
handles missing observations under the MAR assumption. The basic idea of the
reweighted method is first to weight each subject by the inverse of the observation
probability to correct the selection bias created by missingness and then to impose
a simpler selection probability on each subject. Here we suggest setting the im-
posed simpler selection probability as a marginal probability at each time point for
longitudinal study or each period for crossover study. The selection probability is
modeled parametrically. Generally it can be a logistic regression model that regress-
es only on the covariates of the subject. We show that the reweighted GEE (RGEE)
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estimates are asymptotically consistent and normal and that RGEE estimates are
asymptotically more efficient than WGEE estimates.
4.2 Reweighted GEE Estimators
Denote the newly derived weight as qit = ωit/π̄it, where π̄it = λ̄i1 × . . .× λ̄iT ,
λ̄it is the conditional probability of observing subject i at the tth occasion given the
entire history of subject i, and ωit is an observation probability for subject i at time
point t by a logistic regression model that only regresses on the covariates. That is,
logit(ωi) = α0 + α
TXi, where Xi are the covariates.










i △∗i (Yi − µi) = 0, (4.1)
where Di = ∂µ
T
i /∂θ, Vi is the “working” covariance matrix, and △∗i = diag{1, Ri2×
qi2, · · · , RiT × qiT}.
Let Z∗i (ψ) = (U
T
i (θ, α), S
T
i (α))
T , where ψT = (θT , αT ), UTi (θ, α) is the contri-
bution to the score for θ, α from the ith subject, and STi (α) is the contribution to
the score for α from the ith subject. The following regularity conditions are needed
for Theorems 1 and 2:
Regularity Conditions




T , i = 1, . . . , n, are i.i.d.
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3. λ̄it(α) > c > 0 for all α ∈ A, t = (1, . . . , T ) for some c.
4. Eψ0 [Z
∗
i (ψ)] ̸= 0 if ψ ̸= ψ0.
5. var[Z∗i (ψ0)] is finite and positive definite.
6. E[(∂/∂ψT )Z
∗





∥(∂/∂ψT )Z∗i (ψ)∥], E[sup
ψ∈ψ
∥Z∗i (ψ)Z∗i (ψ)T∥] are all finite where
∥A∥ ≡ {ΣijA2ij}1/2 for any matrix A with elements Aij and ψ is the Cartesian
product of α and θ.
8. Li(ψ) is a parametric model for the observed data, where Li(ψ) is a density
that differs from the true density only in that ψ replaces ψ0.
9. For all ψ∗ in a neighborhood N of ψ0, Eψ∗ [Z
∗
i (ψ)] and Eψ∗ [sup
ψ∈ψ
∥Z∗i (ψ)Z∗i (ψ)T∥]
are bounded, where Eψ∗ refers to expectation with respect to Li(ψ
∗)
Theorem 1. Under regularity conditions (1-9) and assumptions (3.3), (3.4), the
solution to the reweighted estimating equations (4.1), θ̂RG, is consistent and asymp-




where Γ = E{(∂Ui(θ)/∂θT )} and Σθ = E[1/π(Y,X)U(Y |X; θ)U(Y |X; θ)T ].
When π̄it is unknown, which is often the case in practice, it can be estimated
in conjunction with estimating θ. Let the new weight be qit(α) = ωit/π̄it(α), where
π̄it(α) = λ̄i1(α)×· · ·×λ̄iT (α), and λ̄it(α) is the corresponding conditional probability.
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Then the reweighting estimating equations are
U(θ, α) = n−1/2
n∑
i=1




















where △∗i (α) = diag{1, Ri2× qi2(α), · · · , RiT × qiT (α)} and Si(α) is the contribution
to the score for α from the ith subject.
Theorem 2. The solution to the reweighted estimating equations (4.3), θ̂RGα, under
regularity conditions (1-9) and assumptions (3.3), (3.4), is consistent and asymp-
totically normal for estimating θ. That is,
√
n(θ̂RGα − θ0)
d→ N(0,Γ−1(Σθ −BΩBT )Γ−1), (4.5)
where Γ = E{∂Ui(θ, α)/∂θT},Σθ = E{Ui(θ, α)Ui(θ, α)T}, B = E{∂Ui(θ, α)/∂αT} =






















Proof of Theorem 1
When π̄it is known, the reweighted estimator, θ̂RG, the estimator obtained by
solving estimating equation (4.1), is consistent (Lehmann and Casella, 1998) because











V −1i Wi(Yi − µi)
]
= 0,
where Wi = diag{1, ωi1, . . . , ωiT}. This follows because given covariate value Xi, π̄it
doesn’t depend on the outcome Yi.
Under regularity conditions (1 − 9), Theorem (3.4) of Newey and McFadden
(1994) implies that with probability approaching 1, θ̂RG exists, is unique and satisfies
√










































where ΣRG = Γ
−1Σθ0Γ
−1.
Proof of Theorem 2
As in Robins, Rotnizky and Zhao (1995) and in Newey and McFadden (1994),






















As E{∂Ui(θ, α)/∂α} = −E{Ui(θ, α)Si(α)T}, which is the “Generalized Infor-
mation Equality” (Pierce, 1982), and
var{Si(α)} = −E{∂Si(α)∂α} = E{Si(α)Si(α)T},
we then obtain
√
n(θ̂RGα − θ0) = Γ−1
n∑
i=1
Resid{Ui(θ, α), Si(α)}+ op(1),
where Γ−1 = −E{∂Ui(θ, α)/∂α}, and
Resid{Ui(θ, α), Si(α)} = Ui(θ, α)− E{Ui(θ, α)Si(α)T}[E{Si(α)Si(α)T}]−1Si(α)
is the residual from the population least squares regression of Ui(θ, α) on Si(α).
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Therefore,
var {Resid[Ui(θ, α)Si(α)]} = Σθ0 −BΩ−1BT ,
where B = E{Ui(θ, α)Si(α)T},Ω = E{Si(α)Si(α)T}. From the central limit the-
orem, the asymptotic distribution of
√
n(θ̂RGα − θ0) is normal with mean 0 and
variance Γ−1(Σθ0 −BΩ−1BT )Γ−1.
If some components of Xi are grouping indicators, the proofs in this section
can be extended to this case, provided that ng, the number of subjects in group g,
goes to infinity and ng → Cg ∈ (0, 1) for g = 1, . . . , G.
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Chapter 5
Application of the Proposed Method in Crossover Study Setting
5.1 Crossover Study and Designs
In a parallel group study, each experimental unit is randomized to receive one
experimental treatment. A crossover study is distinguished from a parallel group
study by each subject’s receiving a sequence of experimental treatments. Note
that typically the aim is still to compare the effects of individual treatments, not
the sequences themselves. The main advantage is that the treatments are com-
pared “within-subject”. Therefore, every subject provides a direct comparison of
the treatments that he or she has received, eliminating many unknown confounders.
Crossover designs remove from the treatment (and period) comparisons any quanti-
ty that is related to the differences between the subjects as it is well known that the
variability of measurements taken on different subjects is far greater than the vari-
ability of repeated measurements taken on the same subject (Jones and Kenward,
2003). Crossover studies have been extensively used in clinical studies, particularly
in the chronic diseases.
Although the use of repeated measurements on the same subject provides great
advantages, it also brings one potential disadvantage, which is the possibility that
the effect of a treatment given in one period might still be present at the start of
the following period. This phenomenon, called “carryover effect”, can be reduced by
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Table 5.1: Orthogonal Latin Square Design for Four Treatments
Period
Sequence 1 2 3 4
1 A B C D
2 B A D C
3 C D A B
4 D C B A
5 A D B C
6 B C A D
7 C B D A
8 D A C B
9 A C D B
10 B D C A
11 C A B D
12 D B A C
wash-out, in which the active effects of a treatment given in the previous period to
be washed out of the body before each subject begins the next period of treatment,
and by the choice of designs and combinations of them, among other methods.
In the presence of carryover effects, in order to have the highest possible effi-
ciency the design must be balanced. The term “balance” refers to the combinatorial
properties that the design must possess: (a) In a balanced design, not only does
each treatment occur once with each subject, but also (b), over the whole design
each treatment occurs the same number of times in each period, and (c) the number
of subjects who receive treatment i in one period followed by treatment j in the
next period is the same for all i ̸= j. This can be achieved by using a complete set
of orthogonal Latin squares.
A complete set of t × t orthogonal Latin squares contains t − 1 squares and
32
Table 5.2: Williams Designs for Four and Three Treatments
Period
Sequence 1 2 3 4
4×4 Williams Design
1 A B D C
2 B C A D
3 C D B A
4 D A C B
3×3 Williams Design
1 A B C
2 B C A
3 C A B
4 A C B
5 B A C
6 C B A
complete sets exist for values of t that are prime or are powers of a prime. A notable
exception is therefore t = 6. Although using orthogonal Latin squares has additional
advantages, they require more subjects and is generally more difficult to execute in
clinical trials. Also, the loss of subjects from the complete set is likely to be more
damaging as its combinatorial structure is more complex.
It was shown that balance could be achieved by a Williams design (Williams,
1949) using only one particular Latin square if t is even and by using only two
particular squares if t is odd. In a Williams design, each treatment precedes every
other treatment, excluding itself, equally often and thus a balance for carryover
effects is achieved. For more than three treatments, a Williams design, therefore,
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requires fewer subjects than complete sets of orthogonal squares. It’s a design
commonly used in crossover clinical trials.
As in longitudinal studies, repeated measures are taken on the same subject in
crossover studies. Similarly, missing data is also a common problem. However, few
studies have been reported in this area. We would like to compare the incomplete
data analysis of both simulated data and industry submitted crossover clinical trial
data using various approaches including full cohort, complete-case analysis, WGEE
and RGEE, our proposed method. Full cohort are the full data without missing
observations while the complete-case method only analyzes the subjects with obser-
vations in every period.
Let p and t denote the number of periods and treatments, respectively. Here
we focus on the crossover designs with p = t.
5.2 Simulations
Simulations were conducted for a 2×2 crossover study and the Williams design
for a 3× 3 crossover study to evaluate the performances of the proposed reweighted
GEE (RGEE) along with full cohort, complete-case and WGEE approaches. The
primary model of interest is the marginal mean of Yit conditional on Xit,
E(Yit|Xit) = µit = g−1(η) = g−1(XTitθ), (5.1)
where θ is a vector of unknown parameters, g is a known link function, and Xi are
covariates used in the simulations. In this chapter, the response variable is assumed
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Table 5.3: Simulation Settings for 2× 2 Crossover Design
Missing Prop. Sample Size Treatment Effect Table
20− 30% 1000 Large vs Small 5.4
40− 50% 1000 Large vs Small 5.5
20− 30% 500 vs 1000 Large 5.6
10− 15% 1000 Large vs Small B.4
60− 70% 1000 Large vs Small B.5
to follow a normal distribution so that g is the identity function.
2× 2 Crossover Study
For 2 × 2 crossover simulation study, we generated 500 replicated study data
sets with sample sizes of N = 500 or 1000. The covariates are treatment, period,
and baseline. It’s assumed that the outcome in period 1 of each subject is always
observed, while the response at period 2 outcome is observed at random according
to a logistic regression model
logit {P (Ri2 = 1|Xi, Yi1)} = α0 + αTxXi + αyYi1, (5.2)
where Xi is the baseline covariates of subject i in period 2 and Yi1 is the observation
in period 1.
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Asymptotic variances of the estimators were estimated using the “sandwich”
estimators, and the efficiency of the RGEE estimators was evaluated relative to
other approaches, particularly relative to those estimated by the WGEE method.
Also studied were the effects of sample size and choice of “working” covariance on
the performances of each approach. Specifically, for studying the effect of sample
size, the performances of the estimators were evaluated for sample sizes of 500 or
1000.
The influence of missing proportions is explored for the 2× 2 crossover study.
The following proportions of missing data were generated under the missing at
random mechanism: 10 − 15%, 20 − 30%, 40 − 50%, and 60 − 70%. It’s generally
known that a large treatment effect is easily detected. To study how the proposed
method performs with small treatment effects, simulations were also run on drug
with small treatment effect coefficient while the other factors were held constant.
As shown in the following Q-Q plots and histograms, the estimates produced
by all the methods generally follow normal distributions. All approaches except
CC analysis produce consistent estimates. Not surprisingly, the full cohort analysis
yields the best estimates in terms of consistency and efficiency. The RGEE esti-
mates are the best among those estimated by all the other approaches. The bias of
the CC analysis becomes more problematic as the missing proportion increases. It’s
also shown that the “sandwich” estimators of standard errors are close to the corre-
sponding true standard errors for each approach across all the missing proportions
(Tables 5.4, 5.5, 5.6, B.4, B.5).
The RGEE estimates are consistently more efficient than WGEE estimates for
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Table 5.4: Simulation Setting 1
2x2 Crossover Study: comparison of the reweighted estimators with WGEE and other methods
estimators under monotone missingness, where 20− 30% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 20− 30%)
Full cohort .002 .007 .005 .644 .286 .412 .645 .287 .416 .954 .955 .957
Complete-Case -.134 -.128 .026 .739 .347 .499 .750 .357 .513 .918 .925 .938
WGEE(α) .020 .029 .007 .830 .399 .439 .847 .413 .446 .943 .945 .952
WGEE(α̂) .019 .025 .007 .812 .396 .438 .828 .407 .444 .944 .948 .954
RGEE(α̂) .018 .023 .007 .717 .347 .431 .727 .353 .435 .943 .947 .952
Small Treatment Effect (mis. pct., 20− 30%)
Full cohort .002 .007 .005 .648 .288 .415 .649 .289 .419 .954 .955 .957
Complete-Case -.136 -.130 .026 .748 .351 .505 .759 .361 .519 .917 .924 .937
WGEE(α) .020 .029 .007 .837 .402 .443 .854 .417 .450 .943 .945 .952
WGEE(α̂) .019 .025 .007 .818 .399 .441 .834 .410 .447 .944 .948 .954
RGEE(α̂) .018 .023 .007 .722 .349 .433 .732 .355 .438 .943 .947 .952
all missing proportions. Specifically, as shown in Table 5.4, the variance of RGEE
improves as much as 25% over WGEE for the treatment effect in the case where
20−30% of the subjects have missing observations in period 2. The improvement for
the intercept is also significant, about 20%, whereas the improvement for baseline
effect is modest. As the missing percentage increases to 40 − 50% (Table 5.5) and
60−70% (B.5), the magnitude of improvement increases to approximately 35% and
40% for the treatment effect respectively. It indicates that the proposed method is
more stable than WGEE as the observation probability becomes small. As expected
from the findings above, with missing proportion dropping to 10 − 15% (B.4), the
improvement decreases correspondingly. The influence of missing observations on
baseline effect is quite limited. Not only is the bias small, but also the variations
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Table 5.5: Simulation Setting 2
2x2 Crossover Study: comparison of the reweighted estimators with WGEE and other methods
estimators under monotone missingness, where 40− 50% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 40− 50%)
Full cohort .005 .007 .005 .645 .287 .413 .646 .288 .417 .953 .954 .957
Complete-Case -.733 -.250 .031 .923 .438 .524 1.01 .478 .563 .855 .915 .927
WGEE(α) .031 .037 .009 1.08 .518 .461 1.21 .578 .495 .921 .935 .943
WGEE(α̂) .028 .034 .009 1.04 .508 .460 1.15 .545 .493 .935 .937 .945
RGEE(α̂) .022 .032 .009 .887 .409 .453 .949 .436 .476 .934 .935 .943
Small Treatment Effect (mis. pct., 40− 50%)
Full cohort .005 .007 .005 .650 .289 .416 .651 .290 .420 .953 .954 .957
Complete-Case -.747 -.255 .032 .937 .445 .532 1.02 .485 .571 .854 .914 .926
WGEE(α) .032 .038 .009 1.09 .523 .465 1.22 .583 .500 .920 .934 .942
WGEE(α̂) .028 .035 .009 1.05 .512 .464 1.16 .549 .497 .935 .937 .945
RGEE(α̂) .022 .033 .009 .894 .412 .456 .956 .439 .479 .934 .935 .943
between sampling variance and sandwich estimator variances are negligible.
The magnitude of improvement in efficiency of RGEE relative to WGEE is
rather remarkable for the treatment effect, which also happens to be the primary
interest of the study. One of the possible explanations might be that unlike other
covariates whose effect can be estimated from early periods, the treatment is dis-
tinctive in each period for a specific subject, and thus the missing information for
the corresponding treatment would be difficult to replace and tends to be more dam-
aging. As a result, it would be more difficult to estimate the treatment effect more
precisely without proper adjustment. Our study also showed that the estimates
from the data generated using small treatment coefficients showed trends similar to
those from the large treatment effect.
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Table 5.6: Simulation Setting 3
2x2 Crossover Study: comparison of the reweighted estimators with WGEE and other methods
estimators under monotone missingness, where approximately 20− 30% of the subjects were
missing observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect
respectively with large treatment effect and different sample size.
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Cohort size 500
Full Cohort .002 .009 .005 .685 .303 .427 .691 .306 .431 .943 .945 .952
Complete-Case -.149 -.131 .030 .852 .403 .512 .873 .411 .520 .806 .838 .840
WGEE(α) .035 .031 .013 .955 .475 .455 .972 .483 .463 .852 .857 .873
WGEE(α̂) .033 .029 .011 .938 .469 .453 .955 .477 .462 .855 .861 .887
RGEE(α̂) .031 .027 .009 .839 .397 .444 .853 .403 .452 .861 .875 .893
Cohort size 1000
Full cohort .002 .007 .005 .644 .286 .412 .645 .287 .416 .954 .955 .957
Complete-Case -.134 -.128 .026 .739 .347 .499 .750 .357 .513 .918 .925 .938
WGEE(α) .020 .029 .007 .830 .399 .439 .847 .413 .446 .943 .945 .952
WGEE(α̂) .019 .025 .007 .812 .396 .438 .828 .407 .444 .944 .948 .954
RGEE(α̂) .018 .023 .007 .717 .347 .431 .727 .353 .435 .943 .947 .952
Compared to the estimators generated from data with 500 patients, those
from the data with 1000 patients showed approximately 20 − 30% improvement in
variances for treatment effects for all the methods other than full cohort analysis,
where the reduction is 10−15%, shown in Table 5.6. The large sample size case, the
RGEE approach is more efficient than WGEE method even when only half of the
patients were enrolled, where the improvements are about 20 − 30% for intercept
and the treatment effect.
Consistent with findings by Robins, Rotnitzky and Zhao (1995), we found that
even when the nonresponse probabilities λ̄it are known, the estimator θ̂, produced
by WGEE(α̂) that uses the estimated probabilities λ̄it(α̂) is at least as efficient as
θ̂∗, the estimator produced by WGEE(α) that uses the true λ̄it.
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3× 3 Williams Design
For Williams design of 3 × 3 crossover study, we generated 500 replicated
study data sets with sample sizes of N = 900 or 1800. As in the 2 × 2 crossover
study, the period 1 outcome of each subject is always observed and the missingness
is monotone. That is, period 3 is missing if period 2 is not observed. Covariates
used in simulating the data include treatment, period, sex, and age and were never
missing. The responses at period 2 and period 3 are observed at random according
to the following logistic regression models:
logit {P (Ri2 = 1|Xi, Yi1)} = α0 + αT1xXi2 + α1yYi1, (5.3)
logit {P (Ri3 = 1|Ri2 = 1, Xi, Yi1, Yi2)} = α0 + αT2xXi3 + α1yYi1 + α2yYi2, (5.4)
where Xi2, Xi3 are covariates of subject i in period 2 and period 3, respectively, and
Yi1, Yi2 are the observed responses in period 1 and period 2, respectively.
We focused on data set with 40 − 50% missing observations in the Williams
3x3 crossover study. Estimators generated by full cohort, CC, WGEE and RGEE
are compared in terms of consistency, efficiency, and the coverage probability. Ad-
ditionally, in order to evaluate the influence of the “working” covariance matrix,
we compared the estimates by analyzing the data using compound symmetry and
unstructured “working” variance-covariance respectively while the true variance-
covariances between observations of period 1, period 2, and period 3 are compound
symmetry. Also compared is the effect of sample size on the estimates. Specifically,
performances of the estimators are evaluated for sample size of 900 or 1800.
The following matrix displays the compound symmetry covariance structure,
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Table 5.7: Simulation Settings for 3× 3 Crossover Design
Missing Prop. Sample Size Treatment Effect Working Cov. Table
40− 50% 900 vs 1800 Large CS 5.8
40− 50% 900 Large CS vs UN 5.9
which implies that the outcome of each time point or period assumes the same
variance and the correlation between any two time points or periods is also the
same.







ρ ρ · · · 1

The more complicated unstructured variance-covariance structure is shown below,
which specifies a completely general T ×T covariance matrix parameterized directly
in terms of variances and covariances.
Unstructured (UN) :

σ21 σ12 · · · σ1T
σ12 σ
2





σ1T σ2T · · · σ2T

The efficiency improvements of RGEE over WGEE vary depending the sample
size and “working” covariance structure used. The variance reduction tends to be
greater for the data of bigger sample size and a “working” covariance that is close to
the true covariance, which is compound symmetry structure in this case. Specifically,
the performance of RGEE is better than WGEE with 25− 30% improvement when
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Table 5.8: Simulation Setting 4
Williams design of 3x3 crossover study: comparison of the reweighted estimators with WGEE
and other methods estimators under monotone missingness, where overall approximately
40− 50% of the subjects were missing observations in period 2, period 3 or both, and θ1, θ2, θ3, θ4
are treatment 1, treatment 2, age, and sex effect respectively, the “working” covariance is
compound symmetry (CS) structure while the true covariance structure is compound symmetry .
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4
Cohort size 900
Full Cohort .008 .002 -.048 .009 .351 .368 .391 .891 .385 .409 .431 .987 .960 .934 .940 .948
Complete-Case -1.04 -.332 -.145 -1.87 .517 .530 .541 1.14 .569 .591 .591 1.26 .586 .832 .838 .685
WGEE(α̂) .117 .034 -.044 -.312 .491 .487 .509 1.11 .551 .543 .569 1.19 .786 .870 .900 0.901
RGEE(α̂) .035 -.010 -.023 -.191 .459 .457 .471 1.03 .506 .507 .536 1.11 .818 .905 .912 .908
Cohort size 1800
Full Cohort .006 .017 -.047 .009 .289 .306 .323 .743 .315 .335 .357 .813 .948 .938 .958 .952
Complete-Case -1.02 -.260 -.121 -1.82 .435 .443 .452 .959 .478 .489 .497 1.07 .603 .903 .915 .752
WGEE(α̂) .090 .028 -.033 -.299 .413 .413 .429 .937 .449 .453 .471 1.03 .874 .906 .938 .902
RGEE(α̂) .014 -.009 -.017 -.172 .355 .353 .373 .819 .388 .391 .409 .897 .906 .914 .941 .918
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Table 5.9: Simulation Setting 5
Williams design of 3x3 crossover study: comparison of the reweighted estimators with WGEE
and other methods estimators under monotone missingness, where overall approximately 40% to
50% of the subjects were missing observations in period 2, period 3 or both, and θ1, θ2, θ3, θ4 are
treatment 1, treatment 2, age, and sex effect respectively, and the sample size is 900 with true
covariance structure as compound symmetry.
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4
Compound Symmetry Covariance (CS)
Full Cohort .008 .002 -.048 .009 .351 .368 .391 .891 .385 .409 .431 .987 .960 .934 .940 .948
Complete-Case -1.04 -.332 -.145 -1.87 .517 .530 .541 1.14 .569 .591 .591 1.26 .586 .832 .838 .685
WGEE(α̂) .117 .034 -.044 -.312 .491 .487 .509 1.11 .551 .543 .569 1.19 .786 .870 .900 0.901
RGEE(α̂) .035 -.010 -.023 -.191 .459 .457 .471 1.03 .506 .507 .536 1.11 .818 .905 .912 .908
Unstructured Covariance (UN)
Full Cohort .008 .002 -.005 .010 .365 .385 .403 .928 .413 .443 .457 1.03 .960 .934 .940 .948
Complete-Case -1.04 -.334 -.145 -1.87 .546 .557 .571 1.19 .613 .632 .641 1.35 .586 .832 .838 .686
WGEE(α̂) .160 .035 -.046 -.330 .519 .515 .539 1.17 .582 .587 .603 1.34 .776 .874 .904 .898
RGEE(α̂) .031 -.013 -.028 -.206 .497 .495 .512 1.12 .558 .563 .583 1.27 .836 .902 .919 .904
the sample size is 1800 and “working” covariance is compound symmetry (Table 5.8),
followed by 10 − 15% improvement for the study with 900 patients and compound
symmetry covariance, and by 5− 10% improvement for the study with 900 patients
and unstructured covariances (Table 5.9).
We observe that the efficiency improved approximately 30 − 40% for all ap-
proaches when the sample size doubles. We also observe that the estimators are
more efficient when the “working” covariances are closer to the true covariances of
the data. Specifically, we observed that the estimators produced by the approaches
using the compound symmetry covariance structure, which is the true covariance
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of the simulated data, as “working” covariance are 10 − 15% more efficient than
the estimators that are obtained using the unstructured covariance as “working”
covariance.
5.3 Application to Data
In this section, we illustrate the proposed method using the QTc study data.
In cardiology, the QT interval is a measure of the time between the start of the
Q wave and the end of the T wave in the heart’s electrical cycle. In general, the
QT interval represents electrical depolarization and repolarization of the left and
right ventricles. QTc is the QT interval corrected for heart rates. A lengthened
QT interval is a biomarker for ventricular tachyarrhythmias like torsades de pointes
(TdP), which is a risk factor for sudden death. TdP was merely an esoteric diagnosis
until the 1980s and 1990s when it was recognized as a major cause of drug-induced
sudden cardiac death. Its recognition prompted the withdrawal of several popular
medications from the market, including Sertindole, an antipsychotic drug, Cisapride,
a GI prokinetic agent, Astemizole, a non-sedating antihistamine, and Grepafloxacin,
an antibiotic. The regulatory guidance for pharmaceutical industry, ICH E14 clinical
evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-
antiarrhythmic drugs, requires all sponsors submitting new drug applications to
conduct a thorough QT/QTc study. A QT study often uses structured crossover
designs such as Latin squares or Williams squares. When ignoring missing data,
the structured design falls back into a random crossover design that suffers loss of
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efficiency in addition to the sample size reduction. The replacement method, the
commonly used method by pharmaceutical companies, replaces a missing subject
with a newly recruited patient, but it is at odds with the idea of intention to treat
(ITT). The data used here is a Williams design of 3×3 crossover study. It has three
arms: placebo, tested drug, and the positive control, 400 mg Moxifloxacin, which is
known to induce QT prolongation.
The primary model is:
E(Yit|Xit) = µit = η = XTitθ, (5.5)
where Yit is the QTc outcome at period t, t = 1, 2, 3, and Xit are covariates. The
MAR missing mechanism is assumed. We use a logistic model for the conditional
probability λ̄it at period t given that it is observed at period t− 1. That is,
λ̄it = logit
−1(αT W̄it), (5.6)
where W̄it is the entire history of subject i before time t.
Complete-case, WGEE and RGEE methods are used to analyze the data,
where about 36 patients are assigned to one of six treatment sequences with 6
patients in each treatment sequence. Approximately 20 − 30% observations were
missing. The coefficients estimated by fitting the model (5.6), shown in Table (5.10),
are used to compute the observation probability. The estimates of the parameters
in model (5.5) and their standard errors as calculated by the complete-case, WGEE,
and RGEE methods are listed in Table 5.11.
Analysis of the QTc data with missing observations showed that the estimators
of RGEE and WGEE methods were much more efficient than those produced by
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Figure 5.1: Schematic representation of Electrocardiogram (ECG)
Table 5.10: Estimated Logistic Model of the Observation Probability
Period 2 Period 3
Parameters Estimate SE Estimate SE
Treatment -2.908 1.489 1.364 0.938
Age -0.075 0.133 0.080 0.069
Sex (Male) 1.517 3.022 0.860 2.014
Race (White) 6.871 5.812 -2.021 2.383
Height -0.942 1.071 -0.624 0.777
Weight 0.821 1.544 0.777 0.928
BMI -0.656 5.277 -2.995 2.872
Y1 (outcome of Period 1) 0.535 0.964 0.319 0.804
Y2 (outcome of Period 2) NA NA 10.404 9.009
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Table 5.11: Analysis of QTc Study Using Various Approaches
Complete-case WGEE RGEE
Effects θ SE θ SE θ SE
Drug 3.980 1.179 3.540 0.193 3.480 0.134
Moxi 11.95 3.534 10.390 0.711 8.640 0.658
Age 0.283 0.215 0.149 0.030 0.220 0.028
Sex (Male) -1.21 3.376 -3.740 0.487 -3.990 0.478
Race (White) 0.051 3.381 -0.862 0.597 -1.213 0.558
BMI 0.211 0.588 0.595 0.107 0.560 0.101
complete-case analysis, and that RGEE consistently performed better than WGEE
with the magnitude of improvement being greater for some effects. Specifically,
for the drug coefficient estimate, the variance improvement of the RGEE method




Conclusions and Future Work
6.1 Conclusions
We have proposed the RGEE method, an approach that is more stable and effi-
cient than WGEE. The estimates by the RGEE method have been shown consistent
and asymptotically normal. We applied the RGEE method along with full cohort,
complete-case, WGEE methods to simulated 2 × 2 crossover and 3 × 3 Williams
design studies, and to real data. Both WGEE and RGEE estimates are consistent
while complete-case estimates are biased, and the bias becomes more problematic as
the missing proportion increases. Our study shows that the RGEE estimators are
consistently more efficient than the WGEE estimators, and that the improvement
is unequivocal and substantial although the magnitude of efficiency improvement
differs as the sample size, missing proportion, or “working” covariance varies. Addi-
tionally, we find that for 2×2 crossover study, the estimates in the cohort size of 500
are fairly unbiased compared to those in the cohort size of 1000 while the estimates
in the cohort size 900 of 3 × 3 Williams design are more biased than those in the
cohort size of 1800. However the variance efficiency improves in both 2×2 and 3×3
simulations with the improvement being greater in 3 × 3 crossover study as sam-
ple size increases. Our study also shows that the efficiency improvement of RGEE
relative to WGEE increases as the missing proportion becomes greater. Among
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other findings is that the RGEE method performs better than the WGEE method
regardless of the choice of “working” covariance. Choosing the “correct” covariance
structure, however, does generally produce more efficient estimators. Consistent
with findings by Robins, Rotnitzky and Zhao (1995), we found that even when the
nonresponse probabilities λ̄it are known, the estimator θ̂, produced by WGEE(α̂)
that uses the estimated probabilities λ̄it(α̂) is at least as efficient as θ̂
∗, the estimator
produced by WGEE(α) that uses the true λ̄it. Application to real data also showed
that the RGEE method is more efficient than the WGEE method.
6.2 Future Work
Unlike longitudinal studies where a patient receives just one treatment and
measured multiple times, crossover studies are more complicated because a patient
receives a different treatment in each period. The reweighted generalized estimating
equations method, although proposed for the crossover studies, can be applied to
other longitudinal studies with slight modifications. As the methods of generalized
estimating equations class have potential to handle the discrete variables well, it will
be interesting to see how the proposed method performs when the missing outcome
follows binary or other discrete distributions. Crossover studies where multiple
measures are taken within each period are particularly difficult to deal with as
the correlations also exist between the time points within each period in addition
to the correlations between periods. It will be valuable to apply the proposed
method to the studies of this nature. Further research regarding the performance
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of the method under the missing not at random mechanism or the nonmonotone
missingness pattern will be certainly informative.
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Appendix A
Q-Q Plots and Histograms









































































Figure A.1: Q-Q Plots of Full Cohort Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline

































































Figure A.2: Histograms of Full Cohort Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline
effects respectively. The sample size is 1000.
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Figure A.3: Q-Q Plots of Complete-Case Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline






























































Figure A.4: Histograms of Complete-Case Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline
effects respectively. The sample size is 1000.
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Figure A.5: Q-Q Plots of WGEE Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline






























































Figure A.6: Histograms of WGEE Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline
effects respectively. The sample size is 1000.
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Figure A.7: Q-Q Plots of RGEE Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline
































































Figure A.8: Histograms of RGEE Analysis
2x2 crossover study, where 20 − 30% of the subjects have missing observations in period 2 under
monotone missingness. Coefficient estimates are for intercept, treatment, period, and baseline
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Table B.1: Simulation Setting 1
2x2 Crossover Study: comparison of the reweighting estimators with WGEE and other methods
estimators under monotone missingness, where 20− 30% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 20− 30%)
Full cohort .002 .007 .005 .644 .286 .412 .645 .287 .416 .954 .955 .957
Complete-Case -.134 -.128 .026 .739 .347 .499 .750 .357 .513 .918 .925 .938
WGEE(α) .020 .029 .007 .830 .399 .439 .847 .413 .446 .943 .945 .952
WGEE(α̂) .019 .025 .007 .812 .396 .438 .828 .407 .444 .944 .948 .954
RGEE(α̂) .018 .023 .007 .717 .347 .431 .727 .353 .435 .943 .947 .952
Small Treatment Effect (mis. pct., 20− 30%)
Full cohort .002 .007 .005 .648 .288 .415 .649 .289 .419 .954 .955 .957
Complete-Case -.136 -.130 .026 .748 .351 .505 .759 .361 .519 .917 .924 .937
WGEE(α) .020 .029 .007 .837 .402 .443 .854 .417 .450 .943 .945 .952
WGEE(α̂) .019 .025 .007 .818 .399 .441 .834 .410 .447 .944 .948 .954
RGEE(α̂) .018 .023 .007 .722 .349 .433 .732 .355 .438 .943 .947 .952
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Table B.2: Simulation Setting 2
2x2 Crossover Study: comparison of the reweighting estimators with WGEE and other methods
estimators under monotone missingness, where 40− 50% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 40− 50%)
Full cohort .005 .007 .005 .645 .287 .413 .646 .288 .417 .953 .954 .957
Complete-Case -.733 -.250 .031 .923 .438 .524 1.01 .478 .563 .855 .915 .927
WGEE(α) .031 .037 .009 1.08 .518 .461 1.21 .578 .495 .921 .935 .943
WGEE(α̂) .028 .034 .009 1.04 .508 .460 1.15 .545 .493 .935 .937 .945
RGEE(α̂) .022 .032 .009 .887 .409 .453 .949 .436 .476 .934 .935 .943
Small Treatment Effect (mis. pct., 40− 50%)
Full cohort .005 .007 .005 .650 .289 .416 .651 .290 .420 .953 .954 .957
Complete-Case -.747 -.255 .032 .937 .445 .532 1.02 .485 .571 .854 .914 .926
WGEE(α) .032 .038 .009 1.09 .523 .465 1.22 .583 .500 .920 .934 .942
WGEE(α̂) .028 .035 .009 1.05 .512 .464 1.16 .549 .497 .935 .937 .945
RGEE(α̂) .022 .033 .009 .894 .412 .456 .956 .439 .479 .934 .935 .943
62
Table B.3: Simulation Setting 3
2x2 Crossover Study: comparison of the reweighting estimators with WGEE and other methods
estimators under monotone missingness, where approximately 20− 30% of the subjects were
missing observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect
respectively with different sample size and large treatment effect size.
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Cohort size 500
Full Cohort .002 .009 .005 .685 .303 .427 .691 .306 .431 .943 .945 .952
Complete-Case -.149 -.131 .030 .852 .403 .512 .873 .411 .520 .806 .838 .840
WGEE(α) .035 .031 .013 .955 .475 .455 .972 .483 .463 .852 .857 .873
WGEE(α̂) .033 .029 .011 .938 .469 .453 .955 .477 .462 .855 .861 .887
RGEE(α̂) .031 .027 .009 .839 .397 .444 .853 .403 .452 .861 .875 .893
Cohort size 1000
Full cohort .002 .007 .005 .644 .286 .412 .645 .287 .416 .954 .955 .957
Complete-Case -.134 -.128 .026 .739 .347 .499 .750 .357 .513 .918 .925 .938
WGEE(α) .020 .029 .007 .830 .399 .439 .847 .413 .446 .943 .945 .952
WGEE(α̂) .019 .025 .007 .812 .396 .438 .828 .407 .444 .944 .948 .954
RGEE(α̂) .018 .023 .007 .717 .347 .431 .727 .353 .435 .943 .947 .952
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Table B.4: Simulation Setting 6
2x2 Crossover Study: comparison of the reweighted estimators with WGEE and other methods
estimators under monotone missingness, where 10− 15% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 10− 15%)
Full cohort .002 .007 .005 .640 .285 .410 .641 .286 .414 .954 .956 .958
Complete-Case -.081 -.017 .012 .662 .313 .494 .673 .319 .499 .939 .941 .948
WGEE(α) .010 .010 .005 .726 .370 .431 .739 .385 .443 .948 .951 .952
WGEE(α̂) .009 .011 .006 .712 .369 .430 .725 .373 .438 .949 .952 .955
RGEE(α̂) .008 .012 .005 .678 .334 .419 .691 .341 .435 .948 .951 .954
Small Treatment Effect (mis. pct., 10− 15%)
Full cohort .002 .007 .005 .644 .286 .412 .645 .287 .416 .954 .956 .958
Complete-Case -.082 -.017 .012 .669 .316 .499 .680 .322 .504 .939 .941 .948
WGEE(α) .010 .010 .005 .732 .373 .434 .745 .388 .447 .948 .951 .952
WGEE(α̂) .009 .011 .006 .717 .372 .433 .730 .376 .441 .949 .952 .955
RGEE(α̂) .008 .012 .005 .682 .336 .422 .695 .343 .438 .948 .951 .954
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Table B.5: Simulation Setting 7
2x2 Crossover Study: comparison of the reweighted estimators with WGEE and other methods
estimators under monotone missingness, where 60− 70% of the subjects were missing
observations in period 2, and θ1, θ2, θ3 are intercept,treatment and baseline effect respectively,
and the sample size is 1000.
Bias Sample SE Mean Theoretical SE 95% CP
Approach θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3 θ1 θ2 θ3
Large Treatment Effect (mis. pct., 60− 70%)
Full cohort .005 .007 .005 .650 .289 .416 .651 .290 .420 .952 .954 .955
Complete-Case -2.12 -.825 -.015 1.16 .617 .78 1.23 .621 .793 .575 .720 .828
WGEE(α) .071 .052 .017 1.57 .798 .521 1.78 .868 .512 .917 .925 .933
WGEE(α̂) .065 .047 .014 1.46 .779 .505 1.65 .848 .505 .927 .937 .942
RGEE(α̂) .062 .045 .011 1.23 .609 .491 1.32 .661 .485 .923 .938 .945
Small Treatment Effect (mis. pct., 60− 70%)
Full cohort .005 .007 .005 .653 .291 .418 .654 .292 .423 .952 .954 .955
Complete-Case -2.16 -.840 -.015 1.18 .627 .792 1.25 .631 .806 .574 .719 .827
WGEE(α) .072 .053 .017 1.58 .805 .526 1.79 .876 .517 .916 .924 .932
WGEE(α̂) .066 .048 .014 1.47 .785 .509 1.66 .855 .509 .926 .936 .941
RGEE(α̂) .063 .046 .011 1.23 .613 .495 1.33 .666 .489 .923 .938 .945
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Table B.6: Simulation Setting 4
Williams design of 3x3 crossover study: comparison of the reweighted estimators with WGEE
and other methods estimators under monotone missingness, where overall approximately
40− 50% of the subjects were missing observations in period 2, period 3 or both, and θ1, θ2, θ3, θ4
are treatment 1, treatment 2, age, and sex effect respectively, the “working” covariance is
compound symmetry (CS) structure while the true covariance structure is compound symmetry .
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4
Cohort size 900
Full Cohort .008 .002 -.048 .009 .351 .368 .391 .891 .385 .409 .431 .987 .960 .934 .940 .948
Complete-Case -1.04 -.332 -.145 -1.87 .517 .530 .541 1.14 .569 .591 .591 1.26 .586 .832 .838 .685
WGEE(α̂) .117 .034 -.044 -.312 .491 .487 .509 1.11 .551 .543 .569 1.19 .786 .870 .900 0.901
RGEE(α̂) .035 -.010 -.023 -.191 .459 .457 .471 1.03 .506 .507 .536 1.11 .818 .905 .912 .908
Cohort size 1800
Full Cohort .006 .017 -.047 .009 .289 .306 .323 .743 .315 .335 .357 .813 .948 .938 .958 .952
Complete-Case -1.02 -.260 -.121 -1.82 .435 .443 .452 .959 .478 .489 .497 1.07 .603 .903 .915 .752
WGEE(α̂) .090 .028 -.033 -.299 .413 .413 .429 .937 .449 .453 .471 1.03 .874 .906 .938 .902
RGEE(α̂) .014 -.009 -.017 -.172 .355 .353 .373 .819 .388 .391 .409 .897 .906 .914 .941 .918
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Table B.7: Simulation Setting 5
Williams design of 3x3 crossover study: comparison of the reweighted estimators with WGEE
and other methods estimators under monotone missingness, where overall approximately 40% to
50% of the subjects were missing observations in period 2, period 3 or both, and θ1, θ2, θ3, θ4 are
treatment 1, treatment 2, age, and sex effect respectively, and the sample size is 900 with true
covariance structure as compound symmetry.
Bias Sample SE Mean theoretical SE 95% CP
Approach θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4 θ1 θ2 θ3 θ4
Compound Symmetry Covariance (CS)
Full Cohort .008 .002 -.048 .009 .351 .368 .391 .891 .385 .409 .431 .987 .960 .934 .940 .948
Complete-Case -1.04 -.332 -.145 -1.87 .517 .530 .541 1.14 .569 .591 .591 1.26 .586 .832 .838 .685
WGEE(α̂) .117 .034 -.044 -.312 .491 .487 .509 1.11 .551 .543 .569 1.19 .786 .870 .900 0.901
RGEE(α̂) .035 -.010 -.023 -.191 .459 .457 .471 1.03 .506 .507 .536 1.11 .818 .905 .912 .908
Unstructured Covariance (UN)
Full Cohort .008 .002 -.005 .010 .365 .385 .403 .928 .413 .443 .457 1.03 .960 .934 .940 .948
Complete-Case -1.04 -.334 -.145 -1.87 .546 .557 .571 1.19 .613 .632 .641 1.35 .586 .832 .838 .686
WGEE(α̂) .160 .035 -.046 -.330 .519 .515 .539 1.17 .582 .587 .603 1.34 .776 .874 .904 .898
RGEE(α̂) .031 -.013 -.028 -.206 .497 .495 .512 1.12 .558 .563 .583 1.27 .836 .902 .919 .904
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